![Lee Aurich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lee Aurich
Profile
Lee Aurich is Chief Financial Officer of CellPoint Diagnostics, Inc. Prior to joining CellPoint Diagnostics, he was Chief Financial Officer of Artemis Health, Inc. He has 18 years of financial experience in insurance, health plan operations, and healthcare delivery.
Mr. Aurich received a BA degree from Pomona College and a Master of Science degree from the Massachusetts Institute of Technology.
Former positions of Lee Aurich
Companies | Position | End |
---|---|---|
Cellective Dx Corp.
![]() Cellective Dx Corp. Pharmaceuticals: GenericHealth Technology Informed decisions will improve the way cancer is treated. On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its platform will enable better decision-making across multiple cancers: improving the cost of treatment, the quality of life for patients and ultimately increasing survival. Products currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream. | Director of Finance/CFO | 2009-11-02 |
Verinata Health, Inc.
![]() Verinata Health, Inc. Medical/Nursing ServicesHealth Services Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA. | Director of Finance/CFO | - |
Training of Lee Aurich
Pomona College | Undergraduate Degree |
Massachusetts Institute of Technology | Graduate Degree |
Experiences
Positions held
Linked companies
Private companies | 2 |
---|---|
Cellective Dx Corp.
![]() Cellective Dx Corp. Pharmaceuticals: GenericHealth Technology Informed decisions will improve the way cancer is treated. On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its platform will enable better decision-making across multiple cancers: improving the cost of treatment, the quality of life for patients and ultimately increasing survival. Products currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream. | Health Technology |
Verinata Health, Inc.
![]() Verinata Health, Inc. Medical/Nursing ServicesHealth Services Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA. | Health Services |
- Stock Market
- Insiders
- Lee Aurich